Christopher Missling of Anavex Life Sciences Corp.
joined us for World Orphan Drug Congress USA 2015 to present about '
Potential Applications of Sigma-1 Receptors in Orphan Indications: Spinocerebellar Ataxia (SCA)'
Download his presentation now to learn about:
-
Description of Spinocerebellar Ataxia (SCA)
-
What are Polyglutamine (PolyQ) Diseases?
-
"Domino Effect" of Polyglutamine (PolyQ) Pathology
-
Possible Multiple Sites for Therapeutic Engagement
...and much more!
Get your copy here!
To find out more about
potential applications of sigma-1 receptors in orphan indications
, attend
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.